Original Article
Baseline ALT levels as a marker of glycemic response to treatment with GLP-1 receptor agonists
Niveles de ALT y respuesta hipoglucemiante al tratamiento con agonistas del receptor de GLP-1
Read
6521
Timeswas read the article
878
Total PDF
5643
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 166 | 20 | 186 |
| 2025 11 | 152 | 39 | 191 |
| 2025 10 | 137 | 13 | 150 |
| 2025 9 | 131 | 14 | 145 |
| 2025 8 | 143 | 16 | 159 |
| 2025 7 | 132 | 12 | 144 |
| 2025 6 | 105 | 5 | 110 |
| 2025 5 | 119 | 5 | 124 |
| 2025 4 | 136 | 5 | 141 |
| 2025 3 | 134 | 11 | 145 |
| 2025 2 | 122 | 9 | 131 |
| 2025 1 | 102 | 1 | 103 |
| 2024 12 | 87 | 1 | 88 |
| 2024 11 | 69 | 5 | 74 |
| 2024 10 | 64 | 2 | 66 |
| 2024 9 | 115 | 7 | 122 |
| 2024 8 | 75 | 3 | 78 |
| 2024 7 | 101 | 6 | 107 |
| 2024 6 | 38 | 2 | 40 |
| 2024 5 | 38 | 7 | 45 |
| 2024 4 | 45 | 6 | 51 |
| 2024 3 | 43 | 8 | 51 |
| 2024 2 | 54 | 10 | 64 |
| 2024 1 | 41 | 4 | 45 |
| 2023 12 | 48 | 12 | 60 |
| 2023 11 | 45 | 6 | 51 |
| 2023 10 | 48 | 10 | 58 |
| 2023 9 | 64 | 9 | 73 |
| 2023 8 | 47 | 10 | 57 |
| 2023 7 | 32 | 7 | 39 |
| 2023 6 | 38 | 10 | 48 |
| 2023 5 | 70 | 5 | 75 |
| 2023 4 | 56 | 8 | 64 |
| 2023 3 | 43 | 6 | 49 |
| 2023 2 | 38 | 5 | 43 |
| 2023 1 | 49 | 7 | 56 |
| 2022 12 | 61 | 11 | 72 |
| 2022 11 | 66 | 10 | 76 |
| 2022 10 | 40 | 10 | 50 |
| 2022 9 | 47 | 13 | 60 |
| 2022 8 | 49 | 10 | 59 |
| 2022 7 | 43 | 9 | 52 |
| 2022 6 | 46 | 4 | 50 |
| 2022 5 | 52 | 9 | 61 |
| 2022 4 | 76 | 16 | 92 |
| 2022 3 | 133 | 6 | 139 |
| 2022 2 | 151 | 13 | 164 |
| 2022 1 | 104 | 11 | 115 |
| 2021 12 | 55 | 13 | 68 |
| 2021 11 | 97 | 13 | 110 |
| 2021 10 | 61 | 12 | 73 |
| 2021 9 | 38 | 11 | 49 |
| 2021 8 | 36 | 8 | 44 |
| 2021 7 | 45 | 9 | 54 |
| 2021 6 | 55 | 13 | 68 |
| 2021 5 | 46 | 12 | 58 |
| 2021 4 | 68 | 17 | 85 |
| 2021 3 | 44 | 2 | 46 |
| 2021 2 | 23 | 12 | 35 |
| 2021 1 | 30 | 7 | 37 |
| 2020 12 | 32 | 6 | 38 |
| 2020 11 | 40 | 10 | 50 |
| 2020 10 | 29 | 8 | 37 |
| 2020 9 | 30 | 12 | 42 |
| 2020 8 | 35 | 9 | 44 |
| 2020 7 | 20 | 12 | 32 |
| 2020 6 | 22 | 9 | 31 |
| 2020 5 | 22 | 13 | 35 |
| 2020 4 | 34 | 8 | 42 |
| 2020 3 | 27 | 6 | 33 |
| 2020 2 | 28 | 8 | 36 |
| 2020 1 | 23 | 4 | 27 |
| 2019 12 | 34 | 6 | 40 |
| 2019 11 | 20 | 3 | 23 |
| 2019 10 | 19 | 3 | 22 |
| 2019 9 | 27 | 6 | 33 |
| 2019 8 | 26 | 4 | 30 |
| 2019 7 | 15 | 12 | 27 |
| 2019 6 | 39 | 3 | 42 |
| 2019 5 | 117 | 29 | 146 |
| 2019 4 | 56 | 22 | 78 |
| 2019 3 | 21 | 4 | 25 |
| 2019 2 | 20 | 3 | 23 |
| 2019 1 | 15 | 3 | 18 |
| 2018 12 | 10 | 2 | 12 |
| 2018 11 | 27 | 6 | 33 |
| 2018 10 | 20 | 5 | 25 |
| 2018 9 | 28 | 4 | 32 |
| 2018 8 | 13 | 7 | 20 |
| 2018 7 | 13 | 1 | 14 |
| 2018 6 | 9 | 4 | 13 |
| 2018 5 | 13 | 5 | 18 |
| 2018 4 | 14 | 6 | 20 |
| 2018 3 | 8 | 4 | 12 |
| 2018 2 | 9 | 1 | 10 |
| 2018 1 | 10 | 0 | 10 |
| 2017 12 | 10 | 3 | 13 |
| 2017 11 | 14 | 2 | 16 |
| 2017 10 | 6 | 2 | 8 |
| 2017 9 | 17 | 17 | 34 |
| 2017 8 | 11 | 2 | 13 |
| 2017 7 | 7 | 10 | 17 |
| 2017 6 | 19 | 18 | 37 |
| 2017 5 | 25 | 4 | 29 |
| 2017 4 | 17 | 3 | 20 |
| 2017 3 | 33 | 1 | 34 |
| 2017 2 | 45 | 1 | 46 |
| 2017 1 | 17 | 3 | 20 |
| 2016 12 | 13 | 3 | 16 |
| 2016 11 | 39 | 1 | 40 |
| 2016 10 | 47 | 2 | 49 |
| 2016 9 | 3 | 0 | 3 |
| 2016 7 | 2 | 1 | 3 |
Show all
